Objective: The aim of Present study was undertaken to evaluate the prevalence of Group D Streptococci or Enterococci isolates, isolated from the various clinical samples and to find out their Antimicrobial sensitivity Pattern.

Materials and Methods: A total of 2915 clinical samples or specimens (Urine, pus, wound swabs, blood cultures, discharges from fistula, peritoneal aspiration fluid, CSF and sputum) from both OPD and IPD of our hospital were received in our department. All samples were processed according to CLSI guidelines. Antimicrobial susceptibility test was done by Kirby Bauer's disc diffusion method. Antimicrobial drugs used are Amoxy-clav, Gentamicin, Azithromycin, Ciprofloxacin, Moxifloxacin, Cefepime + Tazobactum, vancomycin, Linezolid and Teicoplanin.

Results: Out of 2915 clinical samples, a total of 80 isolates (6.62%) of Enterococci were obtained. The highest incidence was from isolates of urine (4.30%), Pus (1.32%), wound swab (0.57%) and the least incidence was from fistula (0.08%), Blood culture (0.08%) and Peritoneal aspiration fluid (0.08%). Majority of Enterococci, 88% of the isolates were Enterococcus faecalis. Antimicrobial sensitivity pattern of the isolates showed 97% sensitivity to vancomycin and 100% sensitivity to the Linezolid and Teicoplanin. Conclusion: Enterococci have emerged as a common cause of Hospital and Hospital acquired infection and incidence to the resistance of antibiotics is increasing. So Irrational and indiscriminate use of antibiotic can be avoided and antibiotic can be used after drug sensitivity testing.

Keywords: Enterococci, Infection, Antibiotics.

1. Guiney M, Urwin G. Frequency and antimicrobial susceptibility of clinical isolates of enterococci. Eur J Clin Microbiol Infect Dis 1993; 12:362-6.
2. Facklam R. Recognition of Group D Streptococcal species of human origin by Biochemical and physiological tests. ApplMicrobiol 1972; 23(6):1131-9.
3. Gorensek MJ, Lebel MH, Nelson JD. Peritonitis in children with nephrotic syndrome. Paediatrics 1988; 81:849-56.
4. Maki DJ, Agger WA. Enterococcal bacteremia: clinical features, the risk of endocarditis and management. Medicine (Baltimore) 1988; 67:248-69.
5. Murray BE. The life & times of the enterococcus. Clin Microbiol Rev 1990; 3:46-65.
6. Wells LD, von Graevenitz A. Clinical significance of enterococci in blood cultures from adult patients. Infection 1980; 4:147-51.
7. Ruoff KL, DeLaMaza L, Murtagh MJ, Spargo MD, Ferraro MJ. Species identities of enterococci isolated from clinical specimens.JClinMicrobiol 1990; 28:435-7.
8. Schaberg DR, Culver DH, Gaynes RP. Major trends in the microbial etiology of nosocomial infection. Am J Med 1991; 91:795-52S.
9. Johnson AP, Uttely AHC, Woodford N, George RC. Resistance to vancomycin and teicoplanin: an emerging clinical problem 1990. Clin Microbiol Rev 1990; 3:280-91.
10. Dobson SRM, Baker CJ. Enterococcal sepsis in neonates: features by age onset and occurrence by focal infection. Paediatrics 1990; 85:165.
11. Schlaes DM, Marino J, Jacobs MR. Infection caused by vancomycin resistant Streptococcus sanguis. II. Antimicrob Agents Chemother 1984; 25:527-8.

Dr Ramanand Kumar Pappu

Associate Professor, Department of Microbiology, Lord Buddha Koshi Medical College and Hospital, Saharsa